课题基金 / 基金详情

Protein Core

Protein Core
蛋白质核心
批准号:
7667780
负责人:
John Atkinson
金额:
$19.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2011-08-31

项目摘要

项目成果

John Atkinson的其他基金

相似基金

相关文献

中文摘要
翻译
为了分析感兴趣的蛋白质,有必要开发可以检测它的试剂。 为了研究蛋白质在风湿性疾病模型中的作用,经常需要使用单克隆抗体, 抗体(mAb)或重组蛋白,其阻断所述蛋白的功能。蛋白质核心 在上一个供资期间,已经建立并取得了成效。协调委员会建议 继续支持该设施,通过1)杂交瘤设施提供服务,以生产新的mAb;以及 2)生产和纯化设施,用于生产高质量的纯化mAb或重组蛋白, 兴趣计划提供新的服务以加强该设施。因此,该设施将继续提供 研究人员拥有大量的蛋白质,可以用来分析它们的分子与 风湿病模型。
英文摘要
To analyze a protein of interest, it is necessary to develop reagents that can detect it. Furthermore, to investigate the role of a protein in rheumatic disease models, it is frequently desirable to use monoclonal antibodies (mAbs) or recombinant proteins that block the function of the protein in question. A Protein Core has been established and has been productive during the last funding period. The RDCC proposes to continue support of this facility to provide services through a 1) Hybridoma facility to produce new mAbs; and 2) Production and Purification facility to produce high quality purified mAbs or recombinant proteins of interest. New services are planned to enhance the facility. Thus, the facility will continue to provide investigators with large quantities of proteins that can be used to analyze their molecules in relationship to rheumatic disease models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Scleroderma Renal Crisis as a Genetic Complementopathy
  • 批准号:
    10159866
  • 项目类别:
  • 资助金额:
    $16.83万
  • 财政年份:
    2020
  • 负责人:
    John Atkinson
  • 依托单位:
Defining the Complosome in Human Cells, Tissues and Disease States
  • 批准号:
    10597611
  • 项目类别:
  • 资助金额:
    $39.37万
  • 财政年份:
    2020
  • 负责人:
    John Atkinson
  • 依托单位:
Defining the Complosome in Human Cells, Tissues and Disease States
  • 批准号:
    10375425
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2020
  • 负责人:
    John Atkinson
  • 依托单位:
Complement Activation Signatures in Systemic Lupus Erythematosus: Castle Study
  • 批准号:
    9317177
  • 项目类别:
  • 资助金额:
    $20.13万
  • 财政年份:
    2017
  • 负责人:
    John Atkinson
  • 依托单位:
海外基金